Hemic & Lymphatic

DC 7705

Immune thrombocytopenia

Educational use only. Not legal or medical advice. Read 38 CFR §4.117 on eCFR
Diagnostic Code
7705
CFR Section
§4.117 — Hemic & Lymphatic

Rating Tiers

100%

Requiring chemotherapy for chronic refractory thrombocytopenia; or a platelet count 30,000 or below despite treatment

70%

Requiring immunosuppressive therapy; or for a platelet count higher than 30,000 but not higher than 50,000, with history of hospitalization because of severe bleeding requiring intravenous immune globulin, high-dose parenteral corticosteroids, and platelet transfusions

30%

Platelet count higher than 30,000 but not higher than 50,000, with either immune thrombocytopenia or mild mucous membrane bleeding which requires oral corticosteroid therapy or intravenous immune globulin

10%

Platelet count higher than 30,000 but not higher than 50,000, not requiring treatment

0%

Platelet count above 50,000 and asymptomatic; or for immune thrombocytopenia in remission

What Raters Look For

Based on M21-1 adjudication criteria for Hemic & Lymphatic conditions. These are the factors a VA rater evaluates when assigning a rating percentage.

M21-1 III.iv.4.G
  • •Complete blood count (CBC) values: hemoglobin, platelet count, white cell count
  • •Whether transfusions are required and how frequently
  • •Bone marrow biopsy or transplant history
  • •Response to treatment and current treatment regimen
  • •Constitutional symptoms: fatigue, weight loss, fever